Hybrid Magnetic Resonance Positron Emission Tomography Is Associated With Cardiac-Related Outcomes in Cardiac Sarcoidosis
Maria Giovanna Trivieri,Philip M Robson,Vittoria Vergani,Gina LaRocca,Angelica M Romero-Daza,Ronan Abgral,Ana Devesa,Levi-Dan Azoulay,Nicolas A Karakatsanis,Aditya Parikh,Christia Panagiota,Anna Palmisano,Louis DePalo,Helena L Chang,Joseph H Rothstein,Rima A Fayad,Marc A Miller,Valentin Fuster,Jagat Narula,Marc R Dweck,Adam Morgenthau,Adam Jacobi,Maria Padilla,Jason C Kovacic,Zahi A Fayad,Philip M. Robson,Angelica M. Romero-Daza,Nicolas A. Karakatsanis,Helena L. Chang,Joseph H. Rothstein,Rima A. Fayad,Marc A. Miller,Marc R. Dweck,Jason C. Kovacic,Zahi A. Fayad
DOI: https://doi.org/10.1016/j.jcmg.2023.11.010
2024-01-01
Abstract:BACKGROUND: Imaging with late gadolinium enhancement (LGE) magnetic resonance (MR) and <sup>18</sup>F-fluorodeoxyglucose (<sup>18</sup>F-FDG) PET allows complementary assessment of myocardial injury and disease activity and has shown promise for improved characterization of active cardiac sarcoidosis (CS) based on the combined positive imaging outcome, MR(+)PET(+).OBJECTIVES: This study aims to evaluate qualitative and quantitative assessments of hybrid MR/PET imaging in CS and to evaluate its association with cardiac-related outcomes.METHODS: A total of 148 patients with suspected CS underwent hybrid MR/PET imaging. Patients were classified based on the presence/absence of LGE (MR+/MR-), presence/absence of <sup>18</sup>F-FDG (PET+/PET-), and pattern of <sup>18</sup>F-FDG uptake (focal/diffuse) into the following categories: MR(+)PET(+)<sub>FOCAL</sub>, MR(+)PET(+)<sub>DIFFUSE</sub>, MR(+)PET(-), MR(-)PET(+)<sub>FOCAL</sub>, MR(-)PET(+)<sub>DIFFUSE</sub>, MR(-)PET(-). Further analysis classified MR positivity based on %LGE exceeding 5.7% as MR(+/-)<sub>5.7%</sub>. Quantitative values of standard uptake value, target-to-background ratio, target-to-normal-myocardium ratio (TNMRmax), and T2 were measured. The primary clinical endpoint was met by the occurrence of cardiac arrest, ventricular tachycardia, or secondary prevention implantable cardioverter-defibrillator (ICD) before the end of the study. The secondary endpoint was met by any of the primary endpoint criteria plus heart failure or heart block. MR/PET imaging results were compared between those meeting or not meeting the clinical endpoints.RESULTS: Patients designated MR(+)<sub>5.7%</sub>PET(+)<sub>FOCAL</sub> had increased odds of meeting the primary clinical endpoint compared to those with all other imaging classifications (unadjusted OR: 9.2 [95% CI: 3.0-28.7]; P = 0.0001), which was higher than the odds based on MR or PET alone. TNMRmax achieved an area under the receiver-operating characteristic curve of 0.90 for separating MR(+)PET(+)<sub>FOCAL</sub> from non-MR(+)PET(+)<sub>FOCAL</sub>, and 0.77 for separating those reaching the clinical endpoint from those not reaching the clinical endpoint.CONCLUSIONS: Hybrid MR/PET image-based classification of CS was statistically associated with clinical outcomes in CS. TNMRmax had modest sensitivity and specificity for quantifying the imaging-based classification MR(+)PET(+)<sub>FOCAL</sub> and was associated with outcomes. Use of combined MR and PET image-based classification may have use in prognostication and treatment management in CS.
radiology, nuclear medicine & medical imaging,cardiac & cardiovascular systems